Wilmer Eye Institute

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Diabetic eye disease2 trials
• High blood pressure1 trial
• Macular degeneration1 trial
• Melanoma1 trial

Phase

• Phase 11 trial
• Phase 21 trial
• Phase 31 trial

Status

• Recruiting3 trials
• Completed1 trial

Lead sponsor

• AbbVie1 trial
• Genentech, Inc.1 trial
• IDEAYA Biosciences1 trial
• Johns Hopkins University1 trial

Running trials

• Recruiting

  A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

  NCT07425522· Phase 1· Genentech, Inc.· Source

• Recruiting

  Neoadjuvant Darovasertib in Primary Uveal Melanoma

  NCT07015190· Phase 3· IDEAYA Biosciences· Source

  Contact: James Handa, MD Principal Investigator

• Recruiting

  Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

  NCT04505618· Johns Hopkins University· Source

  Contact: Ana Collazo Martinez

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Diabetic eye disease2 recruiting
• High blood pressure1 recruiting
• Melanoma1 recruiting

Closed trials

• Completed

  RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)

  NCT04832724· Phase 2· AbbVie· Source